No major new type of antibiotic has been developed since the late 1980s, according to the W.H.O. From 2011 to 2013, the Food and Drug Administration approved only three new molecular entities to combat bacterial diseases â€” the lowest rate since the 1940s. â€œNo sane company will develop the next antibiotic,â€ said Michael S. Kinch, who led a team at the Yale Center for Molecular Discovery tracking the evolution of pharmaceutical innovation over the last two centuries.
Antibiotics face a daunting proposition. They are not only becoming more difficult to develop, but they are also not obviously profitable. Unlike, say, cancer drugs, which can be spectacularly expensive and may need to be taken for life, antibiotics do not command top dollar from hospitals. Whatâ€™s more, they tend to be prescribed for only short periods of time.
Unlimited income while helping others succeed. Only for the educated and qualified entrepreneur.
What could be better than earning up to 100% commission on the sales of exciting cruise and destination vacation packages?
Amazing opportunity for only $500 in an industry that is prime for sales.
Be a part of the number one growth industry while securing your future with residual income.
Earn recurring monthly payments selling mobile websites and apps to local businesses.